101 related articles for article (PubMed ID: 8533125)
1. Effects of VLDL, chylomicrons, and chylomicron remnants on platelet aggregability.
Orth M; Luley C; Wieland H
Thromb Res; 1995 Aug; 79(3):297-305. PubMed ID: 8533125
[TBL] [Abstract][Full Text] [Related]
2. The in vitro effects of chylomicron remnant and very low density lipoprotein remnant on platelet aggregation in blood obtained from healthy persons.
Mochizuki M; Takada Y; Urano T; Nagai N; Nakano T; Nakajima K; Takada A
Thromb Res; 1996 Mar; 81(5):583-93. PubMed ID: 8907317
[TBL] [Abstract][Full Text] [Related]
3. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
Hazzard WR; Bierman EL
Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
[TBL] [Abstract][Full Text] [Related]
4. Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.
Boquist S; Ruotolo G; Hellénius ML; Danell-Toverud K; Karpe F; Hamsten A
Atherosclerosis; 1998 Apr; 137(2):391-400. PubMed ID: 9622282
[TBL] [Abstract][Full Text] [Related]
5. Aggregation of human blood platelets by remnant like lipoprotein particles of plasma chylomicrons and very low density lipoproteins.
Saniabadi AR; Umemura K; Shimoyama M; Adachi M; Nakano M; Nakashima M
Thromb Haemost; 1997 May; 77(5):996-1001. PubMed ID: 9184417
[TBL] [Abstract][Full Text] [Related]
6. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
[TBL] [Abstract][Full Text] [Related]
7. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
Karpe F; Hellénius ML; Hamsten A
Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
[TBL] [Abstract][Full Text] [Related]
8. A novel role for CD36 in VLDL-enhanced platelet activation.
Englyst NA; Taube JM; Aitman TJ; Baglin TP; Byrne CD
Diabetes; 2003 May; 52(5):1248-55. PubMed ID: 12716760
[TBL] [Abstract][Full Text] [Related]
9. Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids.
Westphal S; Orth M; Ambrosch A; Osmundsen K; Luley C
Am J Clin Nutr; 2000 Apr; 71(4):914-20. PubMed ID: 10731497
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantification of triglyceride-rich lipoproteins after an oral fat load.
Tsai MY; Georgopoulos A; Otvos JD; Ordovas JM; Hanson NQ; Peacock JM; Arnett DK
Clin Chem; 2004 Jul; 50(7):1201-4. PubMed ID: 15142979
[TBL] [Abstract][Full Text] [Related]
11. Chylomicrons from patients with type V hyperlipoproteinemia inhibit platelet function.
Aviram M; Furman B; Brook JG
Atherosclerosis; 1985 Aug; 56(2):157-67. PubMed ID: 4074453
[TBL] [Abstract][Full Text] [Related]
12. Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins.
Grønholdt ML; Nordestgaard BG; Nielsen TG; Sillesen H
Stroke; 1996 Dec; 27(12):2166-72. PubMed ID: 8969774
[TBL] [Abstract][Full Text] [Related]
13. Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages.
Gianturco SH; Bradley WA; Gotto AM; Morrisett JD; Peavy DL
J Clin Invest; 1982 Jul; 70(1):168-78. PubMed ID: 6282937
[TBL] [Abstract][Full Text] [Related]
14. Hypertriglyceridemia is exacerbated by slow lipolysis of triacylglycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats.
Mamo JC; Hirano T; Sainsbury A; Fitzgerald AK; Redgrave TG
Biochim Biophys Acta; 1992 Oct; 1128(2-3):132-8. PubMed ID: 1420285
[TBL] [Abstract][Full Text] [Related]
15. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
[TBL] [Abstract][Full Text] [Related]
16. Adenosine 5'-diphosphate as a factor in platelet aggregation induced by human plasma remnant lipoproteins.
Saniabadi AR; Umemura K; Suzuki Y; Kondo K; Ikeda Y; Adachi M; Nakashima M
Life Sci; 1998; 63(12):1065-74. PubMed ID: 9749829
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies of triacylglycerol structure of very low density lipoproteins and chylomicrons of normolipemic subjects and patients with type II hyperlipoproteinemia.
Myher JJ; Kuksis A; Breckenridge WC; McGuire V; Little JA
Lipids; 1985 Feb; 20(2):90-101. PubMed ID: 3982238
[TBL] [Abstract][Full Text] [Related]
18. Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes.
Bozzetto L; Annuzzi G; Corte GD; Patti L; Cipriano P; Mangione A; Riccardi G; Rivellese AA
Atherosclerosis; 2011 Jul; 217(1):142-8. PubMed ID: 21481394
[TBL] [Abstract][Full Text] [Related]
19. Comparison of binding and removal of remnants of triglyceride-rich lipoproteins of intestinal and hepatic origin by rat liver in vitro.
Cooper AD; Shrewsbury MA; Erickson SK
Am J Physiol; 1982 Nov; 243(5):G389-95. PubMed ID: 7137355
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipoprotein and platelet function after heparin injection: studies in normal fasted and postprandial and in type V hyperlipoproteinemic subjects.
Aviram M; Rosenblat M; Potesman M; Dankner G; Brook JG
Biochem Med Metab Biol; 1986 Jun; 35(3):279-92. PubMed ID: 3718760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
